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Targeted Disruption of the Nuclear Receptor
FXR/BAR Impairs Bile Acid and Lipid Homeostasis
proliferator-activated receptor (PPAR), retinoic acid re-
ceptor (RAR), vitamin D receptor, and thyroid hormone
receptor, all of which form heterodimers with a common
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partner known as the retinoid X receptor (RXR). The1 Laboratory of Metabolism
farnesoid X receptor (FXR), which was isolated from aDivision of Basic Sciences
rat liver cDNA library using a degenerate oligonucleotideNational Institutes of Health
probe derived from the highly conserved nuclear recep-Bethesda, Maryland 20892
tor superfamily DNA binding domain (Forman et al.,2 Veterinary and Tumor Pathology Section
1995), belongs to this second group. High concentra-Office of Laboratory Animal Science
tions of farnesol, an isoprene metabolite of the mevalo-
National Cancer Institute
nate pathway, were found to activate FXR (Forman et
National Institutes of Health al., 1995). The mouse ortholog RIP14 was cloned using
Frederick, Maryland 21702 the human RXR ligand binding domain as bait in the
3 Metabolic Disease Branch yeast two-hybrid assay and was found to be activated
National Heart, Lung and Blood Institute only poorly by farnesoids (Seol et al., 1995). Instead,
National Institutes of Health retinoic acid and the synthetic retinoid TTNPB {(E)-4-[2-
Bethesda, Maryland 20892 (5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1-
propenyl] benzoic acid} were demonstrated to be potent
activators of FXR, albeit at supraphysiological concen-
trations (Zavacki et al., 1997). While farnesoids and reti-Summary
noids allowed valuable initial characterizations of FXR,
the high concentrations required for activation sug-Mice lacking the nuclear bile acid receptor FXR/BAR
gested that these compounds were precursors to en-developed normally and were outwardly identical to
dogenous ligands or were mimicking the actions ofwild-type littermates. FXR/BAR null mice were distin-
some other relevant physiological ligand(s).guished from wild-type mice by elevated serum bile
It is well established that bile acids (BAs) regulateacid, cholesterol, and triglycerides, increased hepatic
the expression of a number of transport proteins and
cholesterol and triglycerides, and a proatherogenic biosynthetic enzymes crucial to the maintenance of BA
serum lipoprotein profile. FXR/BAR null mice also had homeostasis (Hylemon et al., 1994; Bahar and Stolz,
reduced bile acid pools and reduced fecal bile acid 1999). These include Ntcp, the hepatic basolateral so-
excretion due to decreased expression of the major dium taurocholate cotransporter protein (Cattori et al.,
hepatic canalicular bile acid transport protein. Bile acid 1999); Bsep, the hepatic canalicular bile salt export
repression and induction of cholesterol 7a-hydroxy- pump (Green et al., 2000); I-BABP (Crossman et al.,
lase and the ileal bile acid binding protein, respectively, 1994), the ileal BA binding protein; and CYP7A (Jelinek
did not occur in FXR/BAR null mice, establishing the et al., 1990), a cholesterol 7a-hydroxylase that is the
regulatory role of FXR/BAR for the expression of these rate-limiting enzyme for the production of BAs from cho-
genes in vivo. These data demonstrate that FXR/BAR lesterol via the neutral biosynthetic pathway (Jelinek et
al., 1990). Recent studies revealed that a number of BAs,is critical for bile acid and lipid homeostasis by virtue
including chendeoxycholic, cholic, deoxycholic, andof its role as an intracellular bile acid sensor.
lithocholic acids, bind and activate FXR/BAR in cultured
cells (Makishima et al., 1999; Parks et al., 1999; WangIntroduction
et al., 1999). Additionally, BA repression of a reporter
gene construct containing a portion of the Cyp7a pro-Nuclear hormone receptors are ligand-activated tran-
moter region was found to be dependent upon cotrans-scription factors that are involved in a variety of physio-
fection with an expression vector for FXR but not otherlogical, developmental, and toxicological processes
nuclear receptors (Makishima et al., 1999). Complemen-(Mangelsdorf et al., 1995; Blumberg and Evans, 1998;
tary to this finding, induction of the human I-BABP geneKliewer et al., 1999). These receptors have highly con-
in response to BAs was shown to be dependent uponserved DNA and ligand binding domains and are sub-
FXR/BAR binding to a highly conserved IR-conservedclassifed into two groups based upon their dimerization
IR-1 (G/A GGTGA A TAACCT) motif (Grober et al., 1999;properties. The first group includes the estrogen, pro-
Makishima et al., 1999). The identification of these genesgesterone, and glucocorticoid receptors, all of which
as targets for FXR provided the first clues to the physio-bind as homodimers to their cognate DNA response
logical function of this receptor. Thus, these data sup-elements. The second group includes the peroxisome
port a role for FXR, hereafter termed FXR/BAR in the
remainder of this report, as an endogenous BA receptor
4 To whom correspondence should be addressed (e-mail: fjgonz@ and a major regulator of BA homeostasis. This is further
helix.nih.gov). supported by the selective expression of this receptor
5 These authors contributed equally to this work. in tissues, such as the liver, ileum, and kidney, that6 Present address: National Institute of Public Health, 4-6-1 Shiro-
are routinely exposed to high concentrations of BAskanedai Minato-ku, Tokyo 108-8638, Japan.
(Forman et al., 1995; Seol et al., 1995).7 Present address: Department of Drug Metabolism and Molecular
To further address the physiological functions of FXR/Toxicology, Faculty of Pharmaceutical Science, Tokohu University,
Sendai 980-8578, Japan. BAR and to specifically examine its role in BA and lipid
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Figure 1. Generation and Analysis of an FXR/BAR Null Mouse
(A) Construction of FXR/BAR targeting vector.
(B) Homologous recombination of the FXR/BAR targeted allele mediated by Cre recombinase.
(C) PCR genotyping of wild-type (lane 1), heterozygous (lane 2), and homozygous (lane 3) FXR/BAR null mice using the primers F1, F2, and
R1. The PCR products (249 bp for wild-type, 291 bp for FXR/BAR null) were separated on a 2% agarose gel.
(D) Northern blot analysis of mouse liver FXR/BAR mRNA expression. Hepatic mRNA (2 mg) from wild-type (1/1) or FXR/BAR null mice (2/2)
mice was separated on a 1.1% agarose gel, transferred to a nylon membrane, and hybridized with the indicated 32P-labeled cDNA probes.
The exon probe is homologous to the deleted exon from the FXR/BAR gene of (2/2), the cDNA probe is homologous to the full-length
transcript from (1/1) mice, and the KO probe is homologous with the unique sequence present within the null mouse mRNA. b-actin was
used as a loading control.
(E) Western blot analysis of mouse liver FXR/BAR protein expression. Hepatic nuclear protein (80 mg) was separated by SDS–PAGE (10%)
and transferred to a nitrocellulose membrane. A goat polyclonal antibody raised against the C-terminal of FXR/BAR was used to assess FXR/
BAR protein expression. The blots were reprobed with an antibody to HNF-4a in order to verify loading and the presence of nuclear proteins
in the samples. Lane 1, 1 ml of sonicate prepared from E. coli expressing murine FXR/BAR; lane 2, wild-type mouse liver; lane 3, FXR/BAR
null mouse liver. Note that the bacterial expressed recombinant protein is 14 amino acids longer than the native protein due to the addition
of a C-terminal histidine tag and adjacent residues encoded by expression vector sequence. A, AvrII; Ap, ApaI; B, BamHI; E, EcoRV; H, HindIII;
N, NcoI; X, XbaI.
homeostasis, a mouse with a targeted disruption of the Southern blot (data not shown) and PCR analysis (Figure
1C) of genomic DNA confirmed the predicted recombi-FXR/BAR gene was constructed. These mice lack func-
nation event after crossing mice homozygous for thetional FXR/BAR and are unable to correctly control BA
targeted allele with transgenic mice expressing bacte-biosynthesis and excretion. The expression of a number
riophage P1 Cre recombinase under the control of theof target genes relevant to these processes, including
adenovirus EIIA promoter. Northern blot analysis of liverCyp7a and I-BABP, was shown to be regulated in an
mRNA from FXR/BAR null (2/2) mice using a cDNAFXR/BAR-dependent manner in vivo. These mice also
probe homologous to the deleted exon indicated theexhibit a potential proatherogenic serum lipoprotein
absence of a wild-type transcript encoding this portionprofile characterized by markedly elevated serum and
of the gene (Figure 1D). Western blot analysis using anliver cholesterol and triglycerides. These results indicate
antibody targeted to the C-terminal portion of FXR/BARthat FXR/BAR is an essential component of the BA and
confirmed the absence of expression of wild-type recep-lipid homeostatic mechanism by serving as an intracellu-
tor in the livers of null mice (Figure 1E). Because thelar sensor of BA concentration.
deleted exon of the FXR/BAR gene encoded not only a
large portion of the ligand binding/dimerization domain
Results (amino acids 406–484) but also all of the 39-untranslated
region, including the poly(A) signal sequence (bases
Targeted Disruption of the FXR/BAR Gene 1228–1779 of the GenBank cDNA sequence NM009108),
Mice with a targeted deletion of the FXR/BAR gene were it was anticipated that no stable transcript would result
produced using the strategy described in the Experi- from the null allele. However, a full length FXR cDNA
probe detected a slightly smaller (1663 bp) and novelmental Procedures and outlined in Figures 1A and 1B.
Targeted Disruption of FXR/BAR
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Figure 2. Bile Acid Homeostasis in FXR/BAR Null Mice
Wild-type (1/1) and FXR/BAR null (2/2) mice were fed a control diet or a diet supplemented with 1% CA for 5 days. (A) Change (percent)
of total body weight and (B) liver/body weight ratios of control and fed mice. (C) Serum BA concentration of control and fed mice. (D) Total
BA pool of control or fed mice. (E) Fecal and (F) urinary BA excretion rate of control or fed mice. Data are mean 6 SD ([A–C], n 5 8; [D], n 5
3; [E], n 5 4; [F], n 5 5). Significant differences compared to wild-type mice fed the same diet: asterisk, p , 0.05; double asterisk, p , 0.01;
triple asterisk, p , 0.001.
transcript expressed only by FXR/BAR null mice (Figure to the dietary administration of BA, mice were fed a diet
supplemented with 1% cholic acid (CA). FXR/BAR null1D). Sequencing of the null transcript of FXR/BAR null
mice fed this diet exhibited severe wasting, hypother-mice revealed complete homology with the wild-type
mia, an absence of adipose tissue, and the death oftranscript up to the position of the predicted deletion,
z30% of the null mice by day 7. In stark contrast, wild-followed by 435 bp of unique sequence that exhibited
type mice appeared to tolerate the CA diet well andno significant homology to any previously characterized
displayed no overt signs of toxicity or mortality after daysequence. A cDNA probe consisting of this unique se-
7. Based on these results, we focused the majority ofquence detected the null transcript only in the FXR/BAR
our studies on mice fed the CA diet for 5 days since bynull mouse liver mRNA sample (Figure 1D). This novel
this time toxicity was readily apparent but mortality wassequence is most likely derived from intron sequence
minimal. Feeding of the 1% CA diet to FXR/BAR nullof the FXR/BAR gene that is not removed during pro-
mice resulted in a progressive decrease in body weightcessing of the primary transcript of the null allele. The
that amounted to approximately one-third of the initialnull transcript possesses a poly(A) signal sequence (AAT
body weight by day 5, while wild-type mice exhibitedAAA) 18 bp upstream of the poly(A) tail that most likely
no significant decrease of body weight (Figure 2A). Liverarises fortuitously as a consequence of the relative
to body weight ratios were similar for both genotypesabundance of these short sequences within genomic
maintained on either diet, indicating an absence of hepa-DNA. Translation of the null-specific mRNA predicts a
tomegaly in FXR/BAR null mice (Figure 2B). Total serumprotein of 376 amino acids compared with the 451 amino
BA concentrations were z8-fold greater for null miceacid product of the wild-type mice transcript.
maintained on a control diet than that for wild-type mice
fed the same diet (Figure 2C). CA-fed FXR/BAR null
Disruption of Bile Acid Homeostasis and Bile Acid mice had dramatically elevated serum BAs that were
Toxicity in FXR/BAR Null Mice 23-fold greater than CA-fed wild-type mice. Histological
Under standard housing and dietary conditions, FXR/ examination revealed that wild-type mice tolerated the
BAR null mice were normal and externally indistinguish- CA diet well and did not exhibit any abnormal degree of
able from wild-type littermates. The null mice were via- individual cell degeneration (Figure 3A) when compared
ble, exhibited normal weight gain, normal development with wild-type mice fed a control diet (data not shown).
and were fertile. Heterozygote crosses produced litters FXR/BAR null mice fed the control diet also did not
with the predicted Mendelian distributions indicating appear to exhibit any substantial signs of hepatotoxicity
that prenatal lethality did not occur with null pups. In when compared with wild-type mice on the same diet
(data not shown). In contrast, lesions indicative of severeorder to investigate the responses of FXR/BAR null mice
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Figure 3. Histology of Livers from Wild-Type
and FXR/BAR Null Mice Fed CA- or Choles-
terol-Supplemented Diets
Hematoxylin- and eosin-stained liver sec-
tions (3003) from wild-type (A) and FXR/BAR
null (B) mice 5 days after feeding. Note the
marked vacuolation and focal necrosis (pale
cells) of hepatocytes in null mice. Oil red O
stained liver sections (1503) from wild-type
(C and E) and FXR/BAR null mice (D and F)
fed a control (C and D) or 1% cholesterol (E
and F) diet for 28 days. Vacuoles containing
lipid stain red in these figures.
hepatotoxicity were present in FXR/BAR null mice fed much higher (7-fold) excretion rates compared with wild-
type mice. These data indicate that FXR/BAR null micethe CA diet, with numerous vacuolated and necrotic
cells evident by day 5 (Figure 3B). These data indicate were deficient for hepatic BA uptake from the blood
and/or hepatic canalicular BA secretion.that FXR/BAR null mice have a reduced capacity to
excrete BAs.
As an indicator of the secretion of BAs from the liver,
total BA pools as well as fecal and urinary BA excretion Defects of Lipid Homeostasis in FXR/BAR
Null Micewere measured. As shown in Figure 2D, wild-type ani-
mals fed the control diet had a BA pool 2-fold greater CYP7A, the rate-limiting enzyme in the elimination of
cholesterol via conversion to BAs, is regulated in anthan FXR/BAR null mice fed the same diet. Similarly,
the BA pool size for CA-fed null mice was substantially FXR/BAR-dependent manner. Thus, we hypothesized
that FXR/BAR null mice would exhibit an inability tolower (2-fold) compared with wild-type mice on the same
diet. Similar to the BA pool data, wild-type animals fed maintain homeostatic control over cholesterol and pos-
sibly other lipids. To test this hypothesis, wild-type anda control diet had a fecal BA excretion rate z2-fold
greater than null mice fed the same diet (Figure 2F). CA FXR/BAR null mice were fed a control diet or a diet
supplemented with 1% cholesterol for 28 days. Histolog-feeding markedly increased (10-fold) fecal BA excretion
in wild-type mice but to a lesser extent (4-fold) in null ical analysis of the livers from mice fed the control diet
revealed the presence of numerous vacuoles in FXR/mice, compared to the corresponding groups fed a con-
trol diet. Under conditions where hepatic elimination is BAR null, but not wild-type mice, that were positive for
the presence of lipid as evidenced by oil red O stainingimpaired, BAs may undergo sulfation resulting in in-
creased hydrophilicity and subsequent renal excretion (Figures 3C and 3D). After 28 days on the 1% cholesterol
diet, numerous lipid-containing vacuoles were present(Bahar and Stolz, 1999). As shown in Figure 2E, wild-
type and null mice exhibited similar rates of urinary BA in the livers of wild-type mice; however, these were
comparatively much smaller and less numerous thanexcretion when fed the control diet. CA feeding in-
creased the rate of urinary BA excretion for both geno- those observed for FXR/BAR null mice fed the same
diet (Figures 3E and 3F). Consistent with these data,types; however, null mice under these conditions had
Targeted Disruption of FXR/BAR
735
Figure 4. Lipid Homeostasis in FXR/BAR Null
Mice
Wild-type (1/1) and FXR/BAR null (2/2)
mice were fed a control diet or a diet supple-
mented with 1% cholesterol for 5 days. (A)
Liver/body weight ratios of control and cho-
lesterol fed mice. Total hepatic cholesterol
(B), triglycerides (C), and phospholipids (D) of
control or 1% cholesterol fed mice. Data are
mean 6 SD (n 5 8). Significant differences
compared to wild-type mice fed the same
diet: asterisk, p , 0.05; double asterisk, p ,
0.01.
FXR/BAR null mice fed the 1% cholesterol diet had a wild-type mice. All of these parameters, with the excep-
tion of triglycerides for wild-type mice, were elevatedliver/body weight ratio 1.6-fold greater than that of wild-
type mice fed the same diet (Figure 4A). Similarly, he- for both genotypes in response to administration of the
1% cholesterol diet for 28 days. Similar to the datapatic cholesterol and triglyceride contents were greater
(1.4- and 2.4-fold, respectively) for FXR/BAR null versus obtained with the control diet, serum total cholesterol,
phospholipid and triglyceride levels for FXR/BAR nullwild-type mice fed the 1% cholesterol diet (Figures 4B
and 4C). The hepatic triglyceride content of FXR/BAR versus wild-type mice were significantly greater when
fed the 1% cholesterol diet. FPLC analysis of the serumnull mice fed the control diet was also significantly
greater (2.2-fold) than that for wild-type mice fed the lipoproteins (Figure 5) revealed that the majority of the
cholesterol eluted in the high-density lipoprotein (HDL)same diet. No differences were observed between geno-
types for liver/body weight ratios or hepatic cholesterol fractions regardless of genotype or diet. However, FXR/
BAR null mice maintained on the control diet had highercontent when the control diet was given, nor for hepatic
phospholipid content (Figure 4D) regardless of diet. levels of very low-density and low-density lipoproteins
(VLDL and LDL, respectively) compared with wild-typeThe serum lipid profiles of wild-type and FXR/BAR
null mice are summarized in Table 1. When maintained mice fed the same diet. Administration of the 1% choles-
terol diet caused similar increases of HDL for both geno-on the control diet, serum total cholesterol, phospho-
lipid, triglyceride, and cholesterol ester levels for FXR/ types but increased LDL only in the FXR/BAR null mice.
Consistent with these data, Western blot analysis of theBAR null mice were significantly greater than those for
Table 1. Serum Lipid Analysis of Wild-Type and FXR/BAR Null Mice Fed either Control or 1% Cholesterol Diet for 28 Days
Control Diet 1% Cholesterol
(1/1) (2/2) (1/1) (2/2)
Total cholesterol 112 6 7 172 6 19a 182 6 21a 274 6 33b,c
Triglycerides 40 6 4 97 6 24a 45 6 6 118 6 22b
Phospholipids 188 6 13 304 6 31a 248 6 28 367 6 50b
Cholesterol Esters 87 6 5 128 6 15a 140 6 16a 162 6 26
Results are expressed as mg/dl and represent the mean 6 SEM (n 5 8). Significant differences are as follows:
a p , 0.05 versus wild-type mice fed the control diet.
b p , 0.05 versus wild-type mice fed the 1% cholesterol diet.
c p , 0.05 versus FXR/BAR null mice fed the control diet.
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Figure 5. Serum Lipoprotein Profiles for Wild-
Type and FXR/BAR Null Mice
Wild-type (1/1) and FXR/BAR null (2/2)
mice fed either a control (chow) or a 1% cho-
lesterol (high cholesterol) diet for 28 days.
Lipoproteins were separated from 60 ml of
pooled (n 5 8 for each group) mouse plasma
samples by FPLC. The concentration of cho-
lesterol in each eluted fraction is indicated
in the y axis. Inset: immunoblot analysis of
apolipoproteins B, E, A-I, and A-II contained
within the VLDL (V), LDL (L), and HDL (H) top
fractions from wild-type and FXR/BAR null
mice fed a control (chow; left panel) or a 1%
cholesterol (high cholesterol; right panel) diet.
apoplipoprotein (apo) content of the VLDL, LDL, and levels were decreased in wild-type but not null mice,
indicating that FXR/BAR is involved in the regulation ofHDL fractions (Figure 5, inset) revealed that FXR/BAR
null mice have increased apoB in the VLDL and HDL expression of this transporter. Organic anion transport
protein-1 (Oatp-1), a basolateral sodium-independentfractions as well as increased apoE in the VLDL, LDL,
and HDL fractions compared with wild-type mice. HDL organic anion transporter that accepts a variety of struc-
turally unrelated amphiphillic compounds, including BAsapoA-I and apoA-II were generally lower in FXR/BAR
null versus wild-type mice regardless of diet, while ad- (Hagenbuch et al., 2000), had similar mRNA levels in the
livers of wild-type and null mice maintained on a controlministration of the 1% cholesterol diet caused an eleva-
tion of apoB, E, A-I, and A-II levels in both genotypes. diet (Figure 6A). Oatp mRNA levels were unaffected by
CA feeding to wild-type mice but were increased in the
livers of null mice maintained on the same diet. It is notDefects of Bile Acid Transport in FXR/BAR
clear from these data whether the lack of a functionalNull Mice
FXR/BAR was related to the increased expression ofTo determine the means by which FXR/BAR exerts con-
Oatp in CA-fed null mice. Microsomal epoxide hydrolasetrol over BA homeostasis, the expression of a number
(mEH), another putative basolateral BA transporter (vonof hepatic and ileal proteins that have been implicated
Dippe et al., 1996), had similar mRNA levels in the liversin BA transport was examined. As shown in Figure 6A,
of wild-type and null mice fed a control diet (Figure 6A).mRNA levels for the hepatic basolateral transporter Ntcp
Because both wild-type and null mice had increasedwere similar for wild-type and null mice fed a control
diet. However, upon feeding the 1% CA diet, Ntcp mRNA levels of hepatic mEH mRNA in response to CA feeding,
Figure 6. Northern Blot Analysis of BA Trans-
port Protein mRNA Levels
Wild-type (1/1) and FXR/BAR null mice
(2/2) mice were fed a control diet or a diet
supplemented with 1% CA for 5 days. Total
RNA was isolated, and 10 mg were separated
on a 1.1% agarose gel, transferred to a nylon
membrane, and hybridized with the indicated
32P-labeled cDNA probes. Quantitation of the
bands was performed using a phosphorim-
ager and are expressed as the fold change,
after correction for b-actin levels, relative to
wild-type mice fed a control diet. Values are
the average obtained from five animals in
each group. Asterisk, significantly different
versus wild-type mice fed a control diet (p ,
0.05).
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it is unlikely that FXR/BAR is involved in regulation of
this gene. Liver fatty acid binding protein (L-FABP), a
member of the 14 kDa supergene family of cytosolic
lipophilic binding proteins (Schroeder et al., 1998), may
facilitate BA uptake and trafficking in hepatocytes and/
or serve as an intracellular buffer to protect against the
harmful detergent effects of BAs. L-FABP mRNA levels
did not differ between wild-type and null mice fed a
control diet but were decreased markedly in CA-fed
wild-type and to a much greater extent in null mice
(Figure 6A). It is not clear from these data whether FXR/
BAR was directly involved in the decreased L-FABP
expression in CA-fed animals as both genotypes exhib-
ited a similar effect, albeit with a much more dramatic
response occurring in null mice. Bsep, the major canalic-
ular bile salt export pump of mammalian liver (Gerloff
et al., 1998), was expressed at much lower levels in null
mice compared with wild-type mice maintained on a
control diet (Figure 6A). CA feeding substantially in-
creased the amount of this transcript in the livers of
wild-type mice but did not increase Bsep mRNA in FXR/
BAR null mice. Furthermore, the levels of Bsep mRNA
in both control and CA-fed FXR/BAR null mice were
much less than those observed for wild-type mice fed
a control diet. These data provide convincing evidence
that FXR/BAR is directly involved in the regulation of
Bsep expression. Targeted gene disruption has demon- Figure 7. Northern Blot Analysis of BA Transport Protein mRNA
strated that the canalicular transport of phospholipids Levels
into the bile is mediated almost entirely by hepatic mdr2 Wild-type (1/1) and FXR/BAR null mice (2/2) mice were fed a
(Smit et al., 1993). Hepatic mRNA levels for mdr2 were control diet or a diet supplemented with 1% CA for 5 days. Total
hepatic RNA was isolated and 10 mg were separated on a 1.1%not significantly affected by disruption of FXR/BAR but
agarose gel, transferred to a nylon membrane, and hybridized withwere increased in both genotypes in response to the
the indicated 32P-labeled cDNA probes. Quantitation of the bands1% CA diet (Figure 6A). These data do not support a
was performed using a phosphorimager and are expressed as therole for FXR/BAR in the regulation of the murine mdr2
fold change, after correction for b-actin levels, relative to wild-typegene.
mice fed a control diet. Values are the average obtained from five
Active BA uptake in the ileum is mediated by a sodium- animals in each group. Asterisk, significantly different versus wild-
dependent ileal BA transport protein (I-BAT) located in type mice fed a control diet (p , 0.05).
the brush border membrane of ileocytes. Once taken
up into the cell, BAs are bound to the I-BABP, which is
closely related in sequence and function to the L-FABP.
was undetectable in the livers of wild-type mice, whileBoth wild-type and FXR/BAR null mice exhibited highly
null mice retained Cyp7a expression levels comparablevariable levels of expression of the mRNA for I-BAT
to those observed for the control diet. CYP7B, an en-(Figure 6B). CA feeding did not have a consistent effect
zyme involved in the acidic BA biosynthetic pathwayon the levels of this transcript in either genotype. In
exhibited similar levels of expression between wild-typecontrast, null mice fed a control diet had no detectable
and null mice fed a control diet (Figure 7). CA feedingI-BABP mRNA, while wild-type mice clearly expressed
caused similar decreases of CYP7B mRNA levels in boththis transcript at readily detectable levels (Figure 6B).
genotypes, indicating that FXR/BAR is not a major regu-Furthermore, CA feeding increased the level of I-BABP
lator of this gene. CYP8B, an important enzyme in bothmRNA in wild-type mice, while this transcript remained
the neutral and acidic pathways, had a pattern of mRNAundetectable in CA-fed null mice. These data provide
expression similar to CYP7A, indicating that the geneconvincing evidence that I-BABP, but not I-BAT, is reg-
encoding this enzyme is also regulated in an FXR/BAR-ulated in an FXR/BAR-dependent manner.
dependent manner (Figure 7). In contrast, CYP27, which
catalyzes the initial step of the acidic pathway, hadDefects of Bile Acid Biosynthesis Regulation
mRNA levels similar for both genotypes regardless of thein FXR/BAR Null Mice
diet (Figure 7), indicating that FXR/BAR is not involved inBiotransformation of cholesterol to BAs occurs exclu-
the regulation of Cyp27.sively in the liver and requires a cascade of numerous
enzymatic reactions performed in various subcellular
organelles (Hylemon et al., 1994; Vlahcevic et al., 1999).
Altered Expression of Other Nuclear ReceptorsTwo alternative BA biosynthetic pathways have been
in FXR/BAR Null Micecharacterized, the neutral and acidic. The initial and
As the preceding data have demonstrated, feeding arate-limiting step in the neutral pathway is catalyzed by
1% CA diet to mice alters the mRNA levels of a numbermicrosomal CYP7A. As shown in Figure 7, CYP7A mRNA
of hepatic and extrahepatic genes in both an FXR/BAR-levels in the livers of FXR/BAR null mice fed the control
dependent and -independent manner. It was thus im-diet were greater than that for wild-type mice adminis-
tered the same diet. Upon CA feeding, CYP7A mRNA portant to determine if CA treatment also affected the
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critical role in the regulation of lipid metabolism (Peters
et al., 1997; Aoyama et al., 1998). As shown in Figure
8, wild-type and null mice expressed similar levels of
hepatic PPARa mRNA whether fed the control or 1%
CA diet. Small heterodimer partner (SHP) is an orphan
nuclear receptor that has been shown to interact with
and inhibit transactivation by a number of nuclear recep-
tors in cell culture cotransfection assays (Seol et al.,
1996, 1997, 1998; Johansson et al., 1999). Interestingly,
hepatic SHP mRNA levels were clearly lower in control
diet fed FXR/BAR null mice compared with wild-type
mice on the same diet (Figure 8). While CA feeding dra-
matically increased SHP mRNA levels in wild-type mice,
the expression of this transcript in null mice was not
affected and remained lower than for wild-type mice on
the control diet. These data indicate that SHP mRNA
levels are basally and inducibly regulated by FXR/BAR.
Discussion
Functional Disruption of FXR/BAR
In order to determine the physiological role of FXR/BAR,
a null mouse was produced. Several lines of evidence
indicate that this mouse lacks functional FXR/BAR ex-
pression. While FXR/BAR null mice produced an mRNA
from the disrupted gene, this transcript is unique to
the knockouts and lacks sequence encoding a critical
portion of the receptor ligand binding/dimerization do-
main. While it cannot be excluded that this truncated
protein was produced and contributed in some mannerFigure 8. Northern Blot Analysis of Mouse Liver Nuclear Receptor
to phenotype of FXR/BAR null mice, this appears verymRNA Levels
unlikely in light of current knowledge of nuclear receptorWild-type (1/1) and FXR/BAR null mice (2/2) mice were fed a
structure and function. Translation of the FXR/BAR nullcontrol diet or a diet supplemented with 1% CA for 5 days. Total
hepatic RNA was isolated, and 10 mg were separated on a 1.1% mRNA predicts a truncated protein missing the N-termi-
agarose gel, transferred to a nylon membrane, and hybridized with nal 74 amino acids of the wild-type protein. Importantly,
the indicated 32P-labeled cDNA probes. Quantitation of the bands this region contains helices 9–10 and the AF2 domain
was performed using a phosphorimager and are expressed as the of FXR/BAR. Previous studies have demonstrated that
fold change, after correction for b-actin levels, relative to wild-type residues contained within helix-10 and in particular the
mice fed a control diet. Values are the average obtained from five ninth heptad are essential for heterodimerization with
animals in each group. Asterisk, significantly different versus wild-
RXR (Zhang et al., 1994; Bourguet et al., 1995; Yang ettype mice fed a control diet (p , 0.05).
al., 1996). In support of this, the recent solution of the
crystal structure for the heterodimer of PPARg/RXR
demonstrated that 21/23 of the amino acids of PPARg
expression of FXR/BAR itself. As shown in Figure 8, that have direct electrostatic and hydrophobic interac-
wild-type animals fed either a control diet or 1% CA had tions with RXR are found within helices 9–10 and the
similar levels of wild-type FXR/BAR mRNA in the liver. AF2 domain (Gampe et al., 2000). Furthermore, many
As expected, expression of this transcript was not de- of the residues within this region of the ligand binding
tected in the liver of null mice fed either control or 1% domain have been shown by x-ray crystallography of
CA diets. Additionally, mRNA expression levels for RXR, other nuclear receptors to form direct contacts with
the heterodimerization partner for FXR/BAR (Forman et ligand (Brzozowski et al., 1997; Nolte et al., 1998; Wil-
al., 1995; Seol et al., 1995), were similar in the livers of liams and Sigler, 1998). Biochemical studies have also
wild-type and null mice fed either a control or 1% CA shown that the AF2 domain is obligatory for transactiva-
diet, indicating that the phenotype of the null mice rela- tion by nuclear receptors and is an important structure
tive to wild-type mice was not due to changes in the for interaction with coactivator and corepressor proteins
expression of RXR. Targeted disruption of the liver oxy- (Bevan et al., 1999; Perissi et al., 1999; Ren et al., 2000).
sterol receptor (LXRa) has demonstrated a critical regu- Thus, it is extremely unlikely that the mRNA expressed
latory function for this nuclear receptor in lipid metabo- in FXR/BAR null mice will result in the expression of a
lism by virtue of its role as a sensor of dietary cholesterol protein with any ability to heterodimerize, bind ligand,
(Peet et al., 1998b). Comparison of hepatic LXRa mRNA or interact effectively with transcriptional cofactors. A
levels in wild-type with null mice fed control diets re- lack of functional FXR/BAR is clearly indicated by the
vealed no obvious differences in expression (Figure 8). absence of responsiveness of the Cyp7a and I-BABP
However, wild-type mice fed a 1% CA diet exhibited genes to dietary BA in FXR/BAR null mice. Previous
increased amounts of this transcript compared with ei- studies, using transactivation reporter gene assays,
ther of the genotypes fed a control diet. LXRa mRNA have shown that these genes are regulated in an FXR/
levels were not increased by CA feeding to null mice, BAR-dependent manner (Grober et al., 1999; Makishima
indicating that functional FXR/BAR is required for this et al., 1999). The absence of prenatal and/or early post-
natal lethality in these mice argues against a criticalinduction. PPARa is another nuclear receptor with a
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role for FXR/BAR in mammalian development, and the has been mapped to chromosome 2 (2q24), a region
that also contains the human Bsep locus (Strautnieksfertility of FXR/BAR null mice indicates that this receptor
et al., 1997). Given the heterogeneity and multiple lociis not essential for reproduction.
that can cause Byler’s disease and the critical role of
FXR/BAR in regulating canalicular BA transport as dem-FXR/BAR Regulation of Bile Acid Transport
onstrated in this study, it remains a possibility that theand Lipid Homeostasis
gene encoding this receptor may be identified in theThe results of this study provide convincing evidence
future as an additional locus for this condition. Thisthat FXR/BAR is critical for BA homeostasis by virtue of
would not be unexpected since the FXR/BAR null is notits role as an intracellular BA sensor and transcriptional
a lethal phenotype.regulator. In hepatocytes, accumulation of BAs is known
In the rat, differential ontogenetic regulation of hepaticto cause mitochondrial damage and, ultimately, apopto-
basolateral and canalicular BA transporters has beensis and necrosis (Roberts et al., 1997; Rodrigues et al.,
reported (Hardikar et al., 1995). In particular, Ntcp and1998). Thus, it is likely that the severe toxicity observed
Bsep mRNA and protein expression levels were foundin null mice fed CA is a direct consequence of the accu-
to be extremely low prior to birth and subsequently in-mulation of these compounds within the body, and in
creased to adult levels by 1 and 4 weeks of life, respec-particular, within the liver. The elevated serum BAs and
tively. Thus, given that control of hepatic BA transporterdecreased BA pool and fecal BA excretion observed for
expression levels is a principal role for FXR/BAR, it isFXR/BAR null mice are consistent with defective BA
not surprising that prenatal effects were not observedtransport. Experimental evidence indicates that canalic-
for null mice. It will be of considerable interest to deter-ular transport of BAs into the bile is the rate-limiting
mine the role that FXR/BAR plays in the developmental
step in BA excretion and that Bsep represents the major expression of these transporters. With respect to the
canalicular bile salt export pump of mammalian liver ileal uptake of BAs, it is clear that FXR/BAR is an impor-
(Gerloff et al., 1998). Thus, it is likely that altered regula- tant regulator of I-BABP expression. Interestingly, ex-
tion of this transporter is a major contributor to the pression of I-BAT was highly variable among all of the
phenotype exhibited by FXR/BAR null mice. mice, and no consistent differences were observed for
FXR/BAR null mice also exhibit severe defects of lipid wild-type versus null mice on either diet. Thus, the role
homeostasis as indicated by elevated levels of hepatic of FXR/BAR in the regulation of active ileal BA uptake
cholesterol and triglycerides, as well as increased apoB- is not clear from our data. The passive uptake of uncon-
containing serum lipoproteins. Despite similar serum jugated BAs, which can occur along most of the entire
HDL levels, VLDL and LDL levels were consistently length of the small intestine (Bahar and Stolz, 1999), did
higher for FXR/BAR null mice compared with wild-type not appear to be impaired in null mice as revealed by
mice. In response to increased dietary cholesterol, FXR/ the accumulation of BAs in the serum of these mice
BAR null mice accumulated LDL and apoE-containing when fed the CA diet. Further study will help to deter-
HDL, two classes of serum lipoproteins associated with mine the effect of FXR/BAR deletion on the uptake tau-
an increased risk of atherosclerosis in mice (Berard et rine- and glycine-conjugated BAs, which occurs primar-
al., 1997; Osuga et al., 1998). Thus, these data indicate ily within the ileum (Aldini et al., 1996).
that FXR/BAR null mice have a potentially proathero-
genic serum lipoprotein profile that is exacerbated by FXR/BAR Regulation of Bile Acid Biosynthesis
increased dietary cholesterol. The biliary secretion of Approximately 50% of the daily secretion of cholesterol
lipids is highly dependent upon BAs formed from the is accomplished by conversion to the primary BAs CA
catabolism of cholesterol. In particular, BAs are required and chendeoxycholic acid (Vlahcevic et al., 1999). The
for solubilization of biliary lipids and create the osmotic data presented in this study provide convincing evi-
potential for canalicular water secretion and, conse- dence in support of a role for FXR/BAR in the regulation
quently, BA flow (Coleman, 1987; Nathanson and Boyer, of expression of a number of enzymes of BA biosynthe-
1991). Thus, it is likely that the aberrant lipid homeosta- sis, particularly those of the neutral pathway. While the
sis observed for null mice was in large part secondary effects of FXR/BAR deletion on the basal expression of
to the defects of BA transport associated with disruption Cyp7a and Cyp8b appeared to be limited, the lack of
of the FXR/BAR gene. Studies are currently underway downregulation of these genes in CA-fed null mice
to identify defects in lipid metabolism directly associ- clearly implicates FXR/BAR in this process. In contrast,
ated with FXR/BAR deletion. Of particular interest is downregulation of CYP7B, an important enzyme of the
a potential regulatory role for FXR/BAR in lipoprotein acidic BA biosynthetic pathway, by CA feeding occurred
metabolism and atherosclerotic disease. with both wild-type and null mice, indicating a lack of
Progressive familial intrahepatic cholestasis (PIFC) involvement of FXR/BAR. The situation for CYP27, an
syndromes represent a diverse group of liver disorders enzyme that catalyzes both the initial step of the acidic
in humans. These diseases are characterized by severe pathway and hydroxylates intermediates of the neutral
intrahepatic cholestasis, a familial or genetic origin, and pathway (Vlahcevic et al., 1999), was somewhat more
defects of BA biosynthesis and/or transport (Balistreri, complex. Cyp7a and Cyp8b are expressed solely in the
1999). Byler’s disease, a specific form of PFIC, repre- liver and appear to function primarily in BA biosynthesis.
sents a progressive cholestatic disease state for which In contrast, Cyp27 is expressed in a number of extrahe-
at least three genetic loci associated with BA excretion patic tissues where FXR/BAR is not coexpressed and
have been identified (Balistreri, 1999; Jansen et al., exhibits a relatively broad selectivity for substrates such
1999). Based upon the apparent similarity of the FXR/ as BA intermediates, cholesterol, and vitamin D3 (Guo
BAR null phenotype to Byler’s syndrome, it is tempting et al., 1993; Lund et al., 1993). Similarly, CYP7B was
to speculate that deficient function of this nuclear recep- originally isolated from a mouse hippocampus cDNA
tor may contribute to some manifestations of this dis- library and can catalyze the 7a-hydroxylation of preg-
nenolone (Schwarz et al., 1997). BAs repress Cyp27ease state in humans. One Byler’s disease locus (PFIC-2)
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Figure 9. A Simplified Model of Regulatory
Targets of FXR in BA and Lipid Homeostasis
Black arrows denote metabolism, transport,
and receptor/ligand interaction steps. Green
and red arrows denote targets for positive and
negative, respectively, transcriptional regula-
tion. Note, while LXR has been shown to posi-
tively regulate Cyp7a, the effects on Cyp8b
are not known. A recent model (Goodwin et
al., 2000; Lu et al., 2000) for indirect regulation
of Cyp7a by FXR/BAR via SHP induction and
SHP/LRH-1 heterodimer formation is shown.
gene transcription in cultured rat hepatocytes (Rao et is an important regulator of lipid metabolism and, thus,
may be functionally linked to FXR/BAR, was also notal., 1999), and promoter deletion analysis has mapped
affected in our study. The apparent role of FXR/BAR inthe BA response element to a region that binds HNF-
LXRa expression regulation is intriguing in light of the1a but does not contain a consensus IR-1 BA response
functional relationship between these receptors for cho-element for FXR/BAR (Grober et al., 1999). Thus, it is
lesterol/BA homeostasis. Thus, in addition to the oppos-unlikely that FXR/BAR fulfills a primary role in the regula-
ing effect of FXR/BAR on the transcriptional regulationtion of Cyp7b and Cyp27.
of genes such as Cyp7a, this receptor may also curbThe Cyp7a promoter is positively regulated by oxyste-
LXRa-mediated transactivation through repression ofrol metabolites of cholesterol that serve as ligands for
its expression. Further study is required to determine ifLXRa (Peet et al., 1998a; Janowski et al., 1999). The
LXRa has a similar effect on FXR/BAR expression. SHProle of LXRa in this regulatory mechanism has been
is an orphan nuclear receptor that does not possess ademonstrated in cell culture (Lehmann et al., 1997) and
DNA binding domain homologous to that of other nu-has been confirmed in vivo by the use of the LXRa null
clear receptor family members (Seol et al., 1996). SHPmouse model (Peet et al., 1998b). The opposing func-
has been shown to interact, both in vitro and in yeasttions of LXRa and FXR/BAR establish an elegant bio-
two-hybrid assays, with several nuclear receptors, in-chemical paradigm of feed-forward and feed-back regu-
cluding RAR, RXR, thyroid hormone receptor, PPAR, CAR,lation by which the liver can respond to the dynamic
HNF-4, and ER (Seol et al., 1996, 1997, 1998; Johanssonlevels of cholesterol and its BA metabolites. The overlap-
et al., 1999; Lee et al., 2000). When examined in cotrans-ping tissue expression pattern of these receptors in the
fection assays, SHP specifically inhibited transactiva-liver, kidney, and intestine (Forman et al., 1995; Seol et
tion by other nuclear receptors, suggesting that it func-al., 1995) also indicates that such coordinate function
tions as a negative regulator of their function. Thus, themay also be relevant extrahepatically. For example, our
level of expression of SHP may be an important determi-data and others (Grober et al., 1999; Makishima et al.,
nant of the transactivation function of a number of re-1999) clearly demonstrate both basal and inducible reg-
ceptor-dependent signaling pathways. A very intriguingulation of I-BABP by FXR/BAR. It will be of considerable
finding of our study was the BA inducibility of SHP ex-interest to determine if LXRa also regulates I-BABP and
pression, which, similar to basal expression, appears toif the tone of this regulation is reversed compared with
be FXR/BAR dependent. The presence of a functionalthat for hepatic Cyp7a.
IR-1 BARE, to which FXR/BAR binds, has recently been
confirmed for the promoter regions of the mouse, rat,
FXR/BAR and Regulation of Nuclear and human SHP genes (Goodwin et al., 2000 [September
Receptor Expression issue of Molecular Cell]). Our data provide convincing
Our observation that CA feeding had no effect on the evidence that FXR/BAR regulates SHP expression in
expression of FXR/BAR argues against autoregulation vivo, raising the possibility of an additional role for FXR/
of this gene by its protein product. The lack of effect of BAR as a regulator of nuclear receptor function by virtue
both FXR/BAR deletion and CA feeding on RXR expres- of its control of SHP expression levels. Consistent with
sion shows that FXR/BAR does not regulate this gene this, recent data (Goodwin et al., 2000; Lu et al., 2000
and that the phenotype of the null mice cannot be attrib- [September issue of Molecular Cell]) indicates that SHP
uted to changes in the level of this dimerization partner represses Cyp7a expression by heterodimerization/inhi-
bition of LRH-1, an orphan receptor that normally bindsfor FXR/BAR. Similarly, PPARa, a nuclear receptor that
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of 728C for 6 min. PCR products were separated on 2% agaroseto a response element in the Cyp7a promoter and acti-
gels using 0.53 TAE (20 mM Tris-acetate, 2 mM Na2EDTA•2H2O,vates transcription. Thus, it appears that while FXR/BAR
pH 8.5) as the running buffer and were visualized under UV lightis required for BA responsiveness of the Cyp7a gene, it
after staining with ethidium bromide.has no direct interaction with the promoter region of
this gene.
Diets, Sample Collection, and Histological Analysis
Mice were housed in a pathogen-free animal facility under standard
Conclusions 12 hr light/12 hr dark cycle. Prior to the administration of special
In conclusion, characterization of the FXR/BAR null diets, mice were fed standard rodent chow and water ad libitum.
mouse provides convincing evidence for a central role All diets were prepared by Bioserv (Frenchtown, NJ) and were based
upon a standard AIN-93G rodent diet containing 58.6% carbohy-of FXR/BAR in BA homeostasis. By extension, FXR/BAR
drate, 18.1% protein, 7.2% fat, 5.1% fiber, 3.4% ash, and 10%is also an important component of lipid homeostasis,
moisture (control diet). Experimental diets consisted of the controlmost likely as consequence of regulation of enzymes
diet supplemented with 1% (w/w) CA or cholesterol. Age- and sex-and transporters that are also critical for lipid catabolism
matched groups of 8- to 12-week-old animals were used for alland excretion. A summary of the regulatory role of FXR/ experiments and were allowed water ad libitum. After 1 day on
BAR in BA transport, biosynthesis, and absorption as the special diets, some animals were placed in Metabowl cages
well as lipid homeostasis is presented in Figure 9. FXR/ (Nalgene, Rochester, NY) for collection of urine and feces for 24 hr.
BAR represents a potentially important target for thera- At the end of the study, animals were fasted for 4 hr and then were
peutic intervention and genetic analysis of a number of euthanized by carbon dioxide asphyxiation or were anaesthetized
with avertin and exsanguinated via the ascending vena cava forcholestatic and lipid related disease states.
blood collection. Animals received a complete necropsy. Tissues
not used for histology were weighed, sectioned, and snap frozenExperimental Procedures
in liquid nitrogen and stored at 2808C until use. For histology, tissues
were fixed in neutral-buffered formalin and embedded in paraffin.Generation of FXR/BAR Null Mice
Sections were cut at 5 mm and stained with hematoxylin and eosinA 129/SVJ BAC library (Genome Systems, St. Louis, MO) was
using standard methods. Some frozen liver sections were stainedscreened with a probe derived from the ligand binding domain of
with oil red O using standard procedures. All protocols and proce-the murine FXR cDNA (Seol et al., 1995). An 11.5 kb AvrII genomic
dures were approved by the NCI Division of Basic Sciences Animalfragment containing the last exon encoding the ligand binding do-
Care and Use Committee and are in accordance with the NIH Guide-main and containing all of the 39-untranslated region of the FXR
lines.mRNA (1228–1779 of cDNA) was isolated. The targeting vector was
constructed by first subcloning this fragment into pGEM3 (Promega,
Madison, WI) and insertion of the first loxP site into the EcoRV site Cloning and Analysis of Gene Expression
Total RNA was prepared using Trizol reagent (GIBCO–BRL, Grandof the AvrII fragment. A BamHI site was also incorporated along
with this loxP site. The second and third loxP sites, flanking the Island, NY) and where indicated was used to isolate poly(A) RNA
by use of an Oligotex mRNA purification kit (Qiagen, Valencia, CA).PGK-neo gene cassette, were inserted into an HindIII site 39 to the
exon in the same orientation as that of the first loxP site. Embryonic Total RNA or mRNA was analyzed by electrophoresis on 0.22 M
formaldehyde-containing 1% agarose gels. The separated RNA wasstem (ES) cells (Genome Systems, St. Louis, MO) were electropo-
rated with the targeting plasmid linearized by SalI. Of 412 analyzed transferred to GeneScreen Plus membranes (NEN Life Science
Products, Boston, MA) by downward capillary transfer in the pres-ES cell colonies surviving selection with G418, five clones contained
a correctly targeted allele as assessed by Southern blotting. These ence of 203 SSC buffer (3 M NaCl, 0.3 M sodium citrate, pH 7.0)
and baked for 2 hr at 808C. Probe hybridization and washing werecells were individually injected into blastocysts derived from C57BL/
6N mice. Two of five ES cell colonies gave rise to chimeric mice performed using standard techniques. Blots were exposed to phos-
phorimager screen cassette and were visualized using a Molecularthat transmitted the targeted allele to the germline (F1 progeny).
Genomic DNA isolated from mouse tail was digested with either Dynamics Storm 860 Phosphorimager system (Sunnyvale, CA). The
cDNA probe for mouse L-FABP was provided by Sam Sorof (FoxBamHI or ApaI and analyzed by Southern blotting (data not shown).
BamHI generated 40 and 20 kb bands for the wild-type and targeted Chase Cancer Center, Philadelphia, PA). cDNA probes for mouse
Bsep (Green et al., 2000), CYP7A (Tzung et al., 1994), CYP7B (Sta-alleles, respectively; ApaI yielded 20 and 12 kb bands for the wild-
type and targeted alleles, respectively. The fidelity of the recombina- pleton et al., 1995), CYP8B (Gafvels et al., 1999), FXR/BAR (Seol et
al., 1995), I-BABP (Crossman et al., 1994), I-BAT (Saeki et al., 1999),tion event was confirmed by hybridization with the neomycin cas-
sette as a probe; only the band corresponding to the targeted allele LXRa (Alberti et al., 2000), mdr2 (Gros et al., 1988), mEH (Miyata et
al., 1999), Ntcp (Cattori et al., 1999), Oatp-1 (Hagenbuch et al., 2000),hybridized with the probe. F1 mice heterozygous for the targeted
allele were crossed with homozygous transgenic mice (pure FVB PPARa (Lee et al., 1995), and SHP (Seol et al., 1996); rat CYP27
(Shayiq and Avadhani, 1992); and human RXRa (Mangelsdorf et al.,background) expressing bacteriophage P1 Cre recombinase under
the control of the viral EIIA promoter (Lakso et al., 1996). This cross 1990) were prepared by RT–PCR of liver or, where appropriate, ileum
total RNA. RT–PCR cloning of the FXR/BAR null mouse mRNA wasproduced chimeric heterozygous mice possessing both the wild-
type FXR/BAR allele and a continuum of potential deletions of the achieved using oligo(dT)30 for both cDNA synthesis and PCR amplifi-
cation and FXR11 (59-tcatattaacagaaatggcaaccagtcatg-39) as thetargeted allele. Male mice highly chimeric for the null allele were
crossed with wild-type female C57BL/6N mice. Black-coated off- upstream PCR primer. Probes were 32P-labeled by the random
primer method using Ready-to-Go DNA labeling beads (Amersham-spring heterozygous for the null allele and not possessing the Cre
transgene were crossed and used to establish the lines used in Pharmacia Biotech, Piscataway, NJ).
Hepatic nuclei were prepared by crushing 0.5 g of frozen tissuethese studies. Routine genotyping of FXR/BAR mice was performed
using the primers F1: 59-tctctttaagtgatgacgggaatct-39; F2: 59-gct using a mortar and pestle on dry ice. The resulting powder was
transferred to a chilled Dounce homogenizer and homogenized, onctaaggagagtcacttgtgca-39; and R1: 59-gcatgctctgttcataaacgccat-39.
Primers F1/R1 predict a 249 bp product, which is preferentially ice, in 10 ml of nuclei buffer (15 mM Tris-HCl, pH 7.4, containing
60 mM KCl, 15 mM NaCl, 5 mM MgCl2, 0.1 mM EGTA, 0.5 mMamplified over the 1989 bp F2/R1 product, for the wild-type allele.
Primers F2/R1 predict a 291 bp product for the null allele. All amplifi- dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, and 300 mM
sucrose). The homogenate was filtered through gauze and centri-cations were performed with 250 ng of genomic DNA using 1.25
U AmpliTaq DNA polymerase (Perkin-Elmer, Norwalk, CT) in the fuged at 4,500 3 g for 4 min at 48C. The resulting pellet was resus-
pended in 5 ml of nuclei buffer, layered over 2.5 ml of nuclei bufferpresence of 2.5 mM MgCl2, 200 mM of each dNTP, and 1 mM of
each primer in a final volume of 25 ml. The following thermal-cycling containing 1.7 M sucrose, and centrifuged at 23,000 3 g for 1 hr at
48C. After aspirating the supernatant, the pellet was resuspendedprofile was used for all PCR reactions: 1 cycle of 5 min at 958C; 30
cycles of 45 s at 958C, 45 s at 608C, and 45 s at 728C; and 1 cycle in 500 ml of nuclei buffer, snap frozen in liquid N2, and stored at 2808C
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until use. The protein concentration of the nuclei was determined transport rates in jejunum and ileum. Gastroenterology 110,
459–468.colorimetrically using a Pierce BCA protein kit (Rockford, IL) using
bovine serum albumin as a standard. SDS–PAGE and Western blot Aoyama, T., Peters, J.M., Iritani, N., Nakajima, T., Furihata, K., Hashi-
analysis of nuclear proteins (80 mg) was performed with a 4% stack- moto, T., and Gonzalez, F.J. (1998). Altered constitutive expression
ing and 10% separating gel using standard methods. The primary of fatty acid-metabolizing enzymes in mice lacking the peroxisome
goat polyclonal anti-mouse FXR antibody (Santa Cruz Biotechnol- proliferator-activated receptor alpha (PPARalpha). J. Biol. Chem.
ogy, Santa Cruz, CA) was diluted 1,000-fold in 1% milk/TTBS (0.1 273, 5678–5684.
M Tris-Cl, 0.9% NaCl, pH 7.5, containing 0.1% Tween). The primary
Bahar, R.J., and Stolz, A. (1999). Bile acid transport. Gastroenterol.
goat polyclonal anti-mouse HNF-4a antibody (Santa Cruz Biotech-
Clin. North Am. 28, 27–58.
nology, Santa Cruz, CA) was diluted 500-fold in 1% milk/TTBS.
Balistreri, W.F. (1999). Inborn errors of bile acid biosynthesis andHistidine-tagged FXR/BAR was generated by PCR subcloning the
transport. Novel forms of metabolic liver disease. Gastroenterol.full-length coding sequence of the murine cDNA into the NdeI–XhoI
Clin. North Am. 28, 145–172.site of pET-30a(1) (Novagen, Madison, WI) and expression in BL21
Berard, A.M., Foger, B., Remaley, A., Shamburek, R., Vaisman, B.L.,E. coli using standard techniques.
Talley, G., Paigen, B., Hoyt, R.F., Jr., Marcovina, S., Brewer, H.B.,
Jr., and Santamarina-Fojo, S. (1997). High plasma HDL concentra-Plasma, Feces, Urine, and Tissue Chemistry
tions associated with enhanced atherosclerosis in transgenic miceSerum was prepared from whole blood by centrifugation at 6,000 3
overexpressing lecithin-cholesteryl acyltransferase. Nat. Med. 3,g using Microtainer serum separator tubes (Becton Dickinson,
744–749.Franklin Lakes, NJ). Total cholesterol and triglyceride (Sigma, St.
Bevan, C.L., Hoare, S., Claessens, F., Heery, D.M., and Parker, M.G.Louis, MO) as well as free cholesterol and phospholipid (Wako,
(1999). The AF1 and AF2 domains of the androgen receptor interactOsaka, Japan) concentrations were measured from 12 ml aliquots
with distinct regions of SRC1. Mol. Cell. Biol. 19, 8383–8392.of serum using commercial kits and the Hitachi 911 automated
chemistry analyzer (Boehringer Mannheim, Indianapolis, IN). FPLC Blumberg, B., and Evans, R.M. (1998). Orphan nuclear receptors—
separation of serum lipoproteins from pooled plasma samples (60 new ligands and new possibilities. Genes Dev. 12, 3149–3155.
ml; n 5 8) was achieved by gel filtration using two Superose 6HR Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H., and Moras, D.
10/30 columns (Amersham-Pharmacia, Piscataway, NJ) in series as (1995). Crystal structure of the ligand-binding domain of the human
previously described (Lambert et al., 2000). Mouse apoA-1, apoA- nuclear receptor RXR-alpha. Nature 375, 377–382.
II, apoE, and apoB were identified by Western blot as previously
Brzozowski, A.M., Pike, A.C., Dauter, Z., Hubbard, R.E., Bonn, T.,described (Lambert et al., 1999), using polyclonal rabbit anti-mouse
Engstrom, O., Ohman, L., Greene, G.L., Gustafsson, J.A., and Carl-IgG raised against the purified apolipoproteins.
quist, M. (1997). Molecular basis of agonism and antagonism in theFor measurement of the BA pool, gall bladders, including the
oestrogen receptor. Nature 389, 753–758.region of liver immediately surrounding the gall bladder, and the
Carr, T.P., Andresen, C.J., and Rudel, L.L. (1993). Enzymatic determi-entire small intestine were homogenized (Omni International, War-
nation of triglyceride, free cholesterol, and total cholesterol in tissuerenton, VA) in 2 ml of water. The resulting homogenate was lyophi-
lipid extracts. Clin. Biochem. 26, 39–42.lized, weighed, and 25 mg was extracted three times with ethanol
at 908C under reflux. The extract was subsequently dried down Cattori, V., Eckhardt, U., and Hagenbuch, B. (1999). Molecular clon-
completely under a stream of N2 and resuspended uniformly by ing and functional characterization of two alternatively spliced Ntcp
ultrasonication in 4 ml of 50% ethanol. Feces samples were lyophi- isoforms from mouse liver. Biochim. Biophys. Acta 1445, 154–159.
lized, weighed, and ground to a fine powder using a pestle. The Coleman, R. (1987). Biochemistry of bile secretion. Biochem. J. 244,
resulting powder was extracted as for the BA pool but resuspended 249–261.
in 2 ml of 50% ethanol. Urine samples were diluted 203 with distilled
Crossman, M.W., Hauft, S.M., and Gordon, J.I. (1994). The mousewater prior to analysis. Total lipids were extracted from liver by
ileal lipid-binding protein gene: a model for studying axial patterninghomogenizing 20 mg of tissue in 2 ml of chloroform:methanol (2:1)
during gut morphogenesis. J. Cell Biol. 126, 1547–1564.as previously described (Carr et al., 1993). The BA content of all
Forman, B.M., Goode, E., Chen, J., Oro, A.E., Bradley, D.J., Perl-samples, including serum, was measured colorimetrically using a
mann, T., Noonan, D.J., Burka, L.T., McMorris, T., Lamph, W.W., etSigma Diagnostics BA analysis kit (St. Louis, MO). Cholesterol, tri-
al. (1995). Identification of a nuclear receptor that is activated byglyceride, and phospholipid concentrations of the resulting extracts
farnesol metabolites. Cell 81, 687–693.were determined as for the serum samples.
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